Arcutis Biotherapeutics Inc (Arcutis) is a biopharmaceutical company. It is in developing small molecules for the treatment of immune-mediated dermatological diseases and conditions. Its pipeline products include a topical roflumilast cream, ARQ-252, a small molecule inhibitor of Janus kinase type 1 (JAK1) to treat rheumatoid arthritis, psoriasis, Crohn’s disease and atopic dermatitis and ARQ-255 for inflammation in alopecia areata. Arcutis other pipeline includes ARQ 252 for the treatment of chronic hand eczema.The company also investigating novel dermatology treatments in inflammation and immunology diseases. Arcutis is headquartered in Westlake Village, California, the US.
Arcutis Biotherapeutics Inc premium industry data and analytics
Products and Services
Products |
---|
Pipeline |
Topical Roflumilast Cream - Palaque Psoaris and Atopic Dermatitis |
Hand Eczema and Vitiligo |
XYZ |
XYZ |
XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2024 | Contracts/Agreements | In February, the company entered into an agreement with Sato Pharmaceutical to develop topical roflumilast in Japan. |
2024 | New Products/Services | In January, the company introduced ZORYVE (roflumilast) topical foam, 0.3%, in the US for treating seborrheic dermatitis. |
2023 | Regulatory Approval | In October, the company's Zoryve (roflumilast) cream 0.3% was approved by the US Food and Drug Administration for the topical treatment of plaque psoriasis in children ages 6 to 11 years. |
Competitor Comparison
Key Parameters | Arcutis Biotherapeutics Inc | AbbVie Inc | Biofrontera Inc | Provectus Biopharmaceuticals Inc | Blacksmith Brands Inc |
---|---|---|---|---|---|
Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
City | Westlake Village | North Chicago | Woburn | Knoxville | Tarrytown |
State/Province | California | Illinois | Massachusetts | Tennessee | New York |
No. of Employees | 296 | 50,000 | 81 | 4 | - |
Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Patrick Heron | Chairman | Executive Board | 2019 | 51 |
Frank Watanabe | Director; Chief Executive Officer; President | Executive Board | 2017 | 55 |
Courtney Barton | Vice President; Chief Compliance Officer | Senior Management | - | - |
Patrick E. Burnett | Senior Vice President; Chief Medical Officer | Senior Management | 2020 | 51 |
Patricia Turney | Senior Vice President - Operations | Senior Management | 2020 | 55 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward